2021 annual financial data
Castle Biosciences, Inc. 2021 Operating margin
Castle Biosciences, Inc. 2021 operating margin with verified reported values.
Direct answer
Operating margin was -42.6%.
Operating income was -40,079,000 USD and net income was -31,292,000 USD.
Operating cash flow was -18,983,000 USD.
Get free Castle Biosciences, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 94,085,000 USD
- Operating income
- -40,079,000 USD
- Net income
- -31,292,000 USD
- Operating cash flow
- -18,983,000 USD